GlaxoSmithKline PLC

30 oct 2024, 11:44 UTC

GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness -- Update

30 oct 2024, 07:50 UTC

GSK Profit Rises on HIV, Cancer Treatments But Sales Slip on Weak U.S. Vaccine Demand

29 oct 2024, 13:39 UTC

GSK Buys Lupus Treatment For Up To $850 Million From Chimagen Biosciences

31 oct 2024, 19:48 UTC

AstraZeneca Probe in China Adds to Concerns for Foreign Businesses -- Update

30 oct 2024, 15:04 UTC

GSK's 3Q Results Are a Mixed Bag -- Market Talk

30 oct 2024, 08:22 UTC

GSK's Vaccine Weakness Is a Major Concern -- Market Talk

30 oct 2024, 07:18 UTC

GSK Reiterates Guidance As HIV And Cancer Drug Demand Offset Vaccine Weakness -- MarketWatch

30 oct 2024, 07:04 UTC

GSK PLC Expects to deliver Around Middle of Existing Annual Guidance Ranges

30 oct 2024, 07:03 UTC

GSK PLC 3Q EPS 1.4p

30 oct 2024, 07:02 UTC

GSK PLC Had Seen 2024 Sales Growth of 7% to 9%

30 oct 2024, 07:02 UTC

GSK PLC Issues Dividend of 15p

30 oct 2024, 07:01 UTC

GSK PLC Had Seen 2024 Core Earnings Per Share Growth of 10% to 12%

30 oct 2024, 07:01 UTC

GSK PLC Had Seen 2024 Core Operating Pft Growth Between 11% and 13%

30 oct 2024, 07:01 UTC

GSK PLC Backs 2024 View

30 oct 2024, 07:00 UTC

Analysts Saw GSK PLC 3Q Net Pft GBP1.78B

30 oct 2024, 07:00 UTC

Analysts Saw GSK PLC 3Q Turnover GBP8.00B

30 oct 2024, 07:00 UTC

GSK PLC 3Q Loss/Shr 1.4p

30 oct 2024, 07:00 UTC

GSK PLC 3Q Turnover GBP8.01B

30 oct 2024, 07:00 UTC

GSK PLC 3Q Adj EPS 49.7p

30 oct 2024, 07:00 UTC

GSK PLC 3Q Pre-items, Pretax Pft GBP2.65B

30 oct 2024, 07:00 UTC

GSK PLC 3Q Pretax Pft GBP64M

30 oct 2024, 07:00 UTC

GSK PLC 3Q Oper Pft GBP189M

30 oct 2024, 07:00 UTC

GSK PLC 3Q Net Loss GBP58M

29 oct 2024, 13:24 UTC

GSK Buys Lupus Treatment For Up To $850 Mln From Chimagen Biosciences

29 oct 2024, 12:58 UTC

GSK to Start Phase I Trial in Lupus in 2025

29 oct 2024, 12:57 UTC

GSK to Pay Extra Sums Based on Development, Commercial Milestones

29 oct 2024, 12:56 UTC

GSK: CMG1A46 Is Currently in Phase I Clinical Trials in Leukaemia, Lymphom

29 oct 2024, 12:55 UTC

GSK to Buy Lupus Treatment CMG1A46 for $300M Upfront Payment

28 oct 2024, 13:48 UTC

Moderna's Stock-Price Target Slashed. It's About Vaccines. -- Barrons.com

14 oct 2024, 08:47 UTC

Stocks to Watch Monday: Tesla, Boeing, Vulcan Materials, GSK -- WSJ